In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) closed the day trading at $14.28 down -11.27% from the previous closing price of $16.1. In other words, the price has decreased by -$11.27 from its previous closing price. On the day, 1.22 million shares were traded. TNXP stock price reached its highest trading level at $15.8 during the session, while it also had its lowest trading level at $14.31.
Ratios:
For a better understanding of TNXP, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.62 and its Current Ratio is at 9.89. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On April 18, 2019, ROTH Capital Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $4.
ROTH Capital Upgraded its Neutral to Buy on August 18, 2017, while the target price for the stock was maintained at $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 21 ’25 when Taylor Carolyn E. bought 418 shares for $36.03 per share. The transaction valued at 15,061 led to the insider holds 418 shares of the business.
Treco James bought 250 shares of TNXP for $9,000 on Aug 20 ’25. The Director now owns 250 shares after completing the transaction at $36.00 per share. On May 15 ’25, another insider, LEDERMAN SETH, who serves as the Chief Executive Officer of the company, bought 4,000 shares for $21.55 each. As a result, the insider paid 86,200 and bolstered with 4,005 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNXP now has a Market Capitalization of 168227904 and an Enterprise Value of -21402098. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.33 while its Price-to-Book (P/B) ratio in mrq is 0.63. Its current Enterprise Value per Revenue stands at -2.078 whereas that against EBITDA is 0.22.
Stock Price History:
The Beta on a monthly basis for TNXP is 1.82, which has changed by -0.15263158 over the last 52 weeks, in comparison to a change of 0.09654534 over the same period for the S&P500. Over the past 52 weeks, TNXP has reached a high of $130.00, while it has fallen to a 52-week low of $6.76. The 50-Day Moving Average of the stock is -30.43%, while the 200-Day Moving Average is calculated to be -45.62%.
Shares Statistics:
Over the past 3-months, TNXP traded about 970.42K shares per day on average, while over the past 10 days, TNXP traded about 861440 shares per day. A total of 11.78M shares are outstanding, with a floating share count of 11.77M. Insiders hold about 0.04% of the company’s shares, while institutions hold 20.10% stake in the company. Shares short for TNXP as of 1761868800 were 1835052 with a Short Ratio of 1.89, compared to 1759190400 on 1930715. Therefore, it implies a Short% of Shares Outstanding of 1835052 and a Short% of Float of 15.989999999999998.
